Original Research
Published on 16 Feb 2026
Computational screening and molecular dynamics reveal curcumin III and taxifolin as potential thyroid receptor modulators for hypothyroidism therapy
in Thyroid Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2026.1727415
- 383 views



